| 1 |
Rao AK, Sobel J, Chatham-Stephens K, et al. Clinical guidelines for diagnosis and treatment of botulism, 2021[J]. MMWR Recomm Rep, 2021, 70 (2): 1-30.
|
| 2 |
Douillard FP, Derman Y, Woudstra C, et al. Genomic and phenotypic characterization of Clostridium botulinum isolates from an infant botulism case suggests adaptation signatures to the gut[J]. mBio, 2022, 13 (3): e0238421.
|
| 3 |
Sobel J, Tucker N, Sulka A, et al. Foodborne botulism in the United States, 1990-2000[J]. Emerg Infect Dis, 2004, 10 (9): 1606-1611.
|
| 4 |
Bai GC, Mi Y, Song Y, et al. Small bowel obstruction caused by secondary jejunal tumor from renal cell carcinoma: a case report[J]. World J Clin Cases, 2021, 9 (19): 5339-5344.
|
| 5 |
彭郁，吴敏仪，林镇洲，等.神经危重症患者床旁肌电图检查的应用价值[J/CD].中华危重症医学杂志（电子版），2018，11（3）：163-167.
|
| 6 |
漆学良，郝洪军，张巍，等. GM1-IgM抗体阳性慢性炎性脱髓鞘性多神经病临床、电生理与病理特点[J].中风与神经疾病杂志，2017，34（3）：213-216.
|
| 7 |
Alpa M, Ferrero B, Cavallo R, et al. Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjogren's syndrome, mixed cryoglobulinemia and idiopathic systemic vasculitis[J]. Clin Exp Rheumatol, 2007, 25 (4): 556-562.
|
| 8 |
Fredman P, Vedeler CA, Nyland H, et al. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin[J]. J Neurol, 1991, 238 (2): 75-79.
|
| 9 |
陈向军，李海峰，邱伟，等.神经免疫疾病与责任抗体[J].中国神经免疫学和神经病学杂志，2021，28（4）：283-287.
|
| 10 |
Berkowitz AL. Tetanus, botulism, and diphtheria[J]. Continuum (Minneap Minn), 2018, 24 (5, Neuroinfectious Disease): 1459-1488.
|
| 11 |
Payne JR, Khouri JM, Jewell NP, et al. Efficacy of human botulism immune globulin for the treatment of infant botulism: the first 12 years post licensure[J]. J Pediatr, 2018 (193): 172-177.
|